Form 4: Cytokinetics Inc. Insider Transactions: John T. Henderson's Stock Activity
Insider Trading Filing
John T. Henderson, an insider at Cytokinetics Inc., engaged in multiple stock transactions on December 11, 2024, including acquisitions and sales of common stock and stock options.
Summary
- On December 11, 2024, John T. Henderson, an insider at Cytokinetics Inc., executed several transactions involving the company's common stock.
- These transactions included the acquisition of 1,780 shares at $7.37 per share and 10,092 shares at $7.37 per share.
- Additionally, 1,780 shares were sold at $50.42 per share.
- The transactions also involved the acquisition of stock options, specifically 1,780 and 10,092 options, at a price of $0 per option.
- These options are non-qualified stock options with an exercise price of $7.37, granted on February 2, 2015, and expiring on January 2, 2025.
Sentiment
Score: 5
Explanation: The document is a factual report of insider trading activity, with no inherent positive or negative sentiment. It reflects normal market operations.
Industry Context
This document reflects routine insider trading activity, which is a common occurrence in publicly traded companies. These transactions are subject to regulatory oversight to prevent insider trading.
Comparison to Industry Standards
- Insider trading activity is a common occurrence in publicly traded companies, and the transactions reported here are within the normal range of such activities.
- The reported transactions are similar to those of other executives in comparable biotech companies, where stock options and share sales are part of compensation packages.
- The price at which the shares were sold ($50.42) is significantly higher than the price at which they were acquired ($7.37), which could indicate a positive trend in the company's stock value.
Stakeholder Impact
- The transactions may have a minor impact on the stock price, but are unlikely to significantly affect shareholders.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2015-02-02 | Grant date of the non-qualified stock options. |
| 2024-12-11 | Date of the stock and stock option transactions. |
| 2024-12-12 | Date the filing was signed by attorney-in-fact. |
| 2025-01-02 | Expiration date of the non-qualified stock options. |
Keywords
Cytokinetics Inc, Insider Trading, Stock Transactions, Common Stock, Stock Options, John T. Henderson, Equity, Non-Qualified Stock Option
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.